---
annotations:
- type: Pathway Ontology
  value: regulatory pathway
- type: Pathway Ontology
  value: oxidative stress response pathway
authors:
- ReactomeTeam
- Ryanmiller
description: Oxidative stress, caused by increased concentration of reactive oxygen
  species (ROS) in the cell, can happen as a consequence of mitochondrial dysfunction
  induced by the oncogenic RAS (Moiseeva et al. 2009) or independent of oncogenic
  signaling. Prolonged exposure to interferon-beta (IFNB, IFN-beta) also results in
  ROS increase (Moiseeva et al. 2006). ROS oxidize thioredoxin (TXN), which causes
  TXN to dissociate from the N-terminus of MAP3K5 (ASK1), enabling MAP3K5 to become
  catalytically active (Saitoh et al. 1998). ROS also stimulate expression of Ste20
  family kinases MINK1 (MINK) and TNIK through an unknown mechanism, and MINK1 and
  TNIK positively regulate MAP3K5 activation (Nicke et al. 2005).<p> <br>MAP3K5 phosphorylates
  and activates MAP2K3 (MKK3) and MAP2K6 (MKK6) (Ichijo et al. 1997, Takekawa et al.
  2005), which act as p38 MAPK kinases, as well as MAP2K4 (SEK1) (Ichijo et al. 1997,
  Matsuura et al. 2002), which, together with MAP2K7 (MKK7), acts as a JNK kinase.<p>
  <br>MKK3 and MKK6 phosphorylate and activate p38 MAPK alpha (MAPK14) and beta (MAPK11)
  (Raingeaud et al. 1996), enabling p38 MAPKs to phosphorylate and activate MAPKAPK2
  (MK2) and MAPKAPK3 (MK3) (Ben-Levy et al. 1995, Clifton et al. 1996, McLaughlin
  et al. 1996, Sithanandam et al. 1996, Meng et al. 2002, Lukas et al. 2004, White
  et al. 2007), as well as MAPKAPK5 (PRAK) (New et al. 1998 and 2003, Sun et al. 2007).<p>
  <br>Phosphorylation of JNKs (MAPK8, MAPK9 and MAPK10) by MAP3K5-activated MAP2K4
  (Deacon and Blank 1997, Fleming et al. 2000) allows JNKs to migrate to the nucleus
  (Mizukami et al. 1997) where they phosphorylate JUN. Phosphorylated JUN binds FOS
  phosphorylated by ERK1 or ERK2, downstream of activated RAS (Okazaki and Sagata
  1995, Murphy et al. 2002), forming the activated protein 1 (AP-1) complex (FOS:JUN
  heterodimer) (Glover and Harrison 1995, Ainbinder et al. 1997). <p> <br>Activation
  of p38 MAPKs and JNKs downstream of MAP3K5 (ASK1) ultimately converges on transcriptional
  regulation of CDKN2A locus. In dividing cells, nucleosomes bound to the CDKN2A locus
  are trimethylated on lysine residue 28 of histone H3 (HIST1H3A) by the Polycomb
  repressor complex 2 (PRC2), creating the H3K27Me3 (Me3K-28-HIST1H3A) mark (Bracken
  et al. 2007, Kotake et al. 2007). The expression of Polycomb constituents of PRC2
  (Kuzmichev et al. 2002) - EZH2, EED and SUZ12 - and thereby formation of the PRC2,
  is positively regulated in growing cells by E2F1, E2F2 and E2F3 (Weinmann et al.
  2001, Bracken et al. 2003). H3K27Me3 mark serves as a docking site for the Polycomb
  repressor complex 1 (PRC1) that contains BMI1 (PCGF4) and is therefore named PRC1.4,
  leading to the repression of transcription of p16INK4A and p14ARF from the CDKN2A
  locus, where PCR1.4 mediated repression of p14ARF transcription in humans may be
  context dependent (Voncken et al. 2005, Dietrich et al. 2007, Agherbi et al. 2009,
  Gao et al. 2012). MAPKAPK2 and MAPKAPK3, activated downstream of the MAP3K5-p38
  MAPK cascade, phosphorylate BMI1 of the PRC1.4 complex, leading to dissociation
  of PRC1.4 complex from the CDKN2A locus and upregulation of p14ARF transcription
  (Voncken et al. 2005). AP-1 transcription factor, formed as a result of MAP3K5-JNK
  signaling, as well as RAS signaling, binds the promoter of KDM6B (JMJD3) gene and
  stimulates KDM6B expression. KDM6B is a histone demethylase that removes H3K27Me3
  mark i.e. demethylates lysine K28 of HIST1H3A, thereby preventing PRC1.4 binding
  to the CDKN2A locus and allowing transcription of p16INK4A (Agger et al. 2009, Barradas
  et al. 2009, Lin et al. 2012).<p> <br>p16INK4A inhibits phosphorylation-mediated
  inactivation of RB family members by CDK4 and CDK6, leading to cell cycle arrest
  (Serrano et al. 1993). p14ARF inhibits MDM2-mediated degradation of TP53 (p53) (Zhang
  et al. 1998), which also contributes to cell cycle arrest in cells undergoing oxidative
  stress. In addition, phosphorylation of TP53 by MAPKAPK5 (PRAK) activated downstream
  of MAP3K5-p38 MAPK signaling, activates TP53 and contributes to cellular senescence
  (Sun et al. 2007).   View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=2559580
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3404
- /instance/WP3404
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3404.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Oxidative stress, caused by increased concentration of reactive oxygen
    species (ROS) in the cell, can happen as a consequence of mitochondrial dysfunction
    induced by the oncogenic RAS (Moiseeva et al. 2009) or independent of oncogenic
    signaling. Prolonged exposure to interferon-beta (IFNB, IFN-beta) also results
    in ROS increase (Moiseeva et al. 2006). ROS oxidize thioredoxin (TXN), which causes
    TXN to dissociate from the N-terminus of MAP3K5 (ASK1), enabling MAP3K5 to become
    catalytically active (Saitoh et al. 1998). ROS also stimulate expression of Ste20
    family kinases MINK1 (MINK) and TNIK through an unknown mechanism, and MINK1 and
    TNIK positively regulate MAP3K5 activation (Nicke et al. 2005).<p> <br>MAP3K5
    phosphorylates and activates MAP2K3 (MKK3) and MAP2K6 (MKK6) (Ichijo et al. 1997,
    Takekawa et al. 2005), which act as p38 MAPK kinases, as well as MAP2K4 (SEK1)
    (Ichijo et al. 1997, Matsuura et al. 2002), which, together with MAP2K7 (MKK7),
    acts as a JNK kinase.<p> <br>MKK3 and MKK6 phosphorylate and activate p38 MAPK
    alpha (MAPK14) and beta (MAPK11) (Raingeaud et al. 1996), enabling p38 MAPKs to
    phosphorylate and activate MAPKAPK2 (MK2) and MAPKAPK3 (MK3) (Ben-Levy et al.
    1995, Clifton et al. 1996, McLaughlin et al. 1996, Sithanandam et al. 1996, Meng
    et al. 2002, Lukas et al. 2004, White et al. 2007), as well as MAPKAPK5 (PRAK)
    (New et al. 1998 and 2003, Sun et al. 2007).<p> <br>Phosphorylation of JNKs (MAPK8,
    MAPK9 and MAPK10) by MAP3K5-activated MAP2K4 (Deacon and Blank 1997, Fleming et
    al. 2000) allows JNKs to migrate to the nucleus (Mizukami et al. 1997) where they
    phosphorylate JUN. Phosphorylated JUN binds FOS phosphorylated by ERK1 or ERK2,
    downstream of activated RAS (Okazaki and Sagata 1995, Murphy et al. 2002), forming
    the activated protein 1 (AP-1) complex (FOS:JUN heterodimer) (Glover and Harrison
    1995, Ainbinder et al. 1997). <p> <br>Activation of p38 MAPKs and JNKs downstream
    of MAP3K5 (ASK1) ultimately converges on transcriptional regulation of CDKN2A
    locus. In dividing cells, nucleosomes bound to the CDKN2A locus are trimethylated
    on lysine residue 28 of histone H3 (HIST1H3A) by the Polycomb repressor complex
    2 (PRC2), creating the H3K27Me3 (Me3K-28-HIST1H3A) mark (Bracken et al. 2007,
    Kotake et al. 2007). The expression of Polycomb constituents of PRC2 (Kuzmichev
    et al. 2002) - EZH2, EED and SUZ12 - and thereby formation of the PRC2, is positively
    regulated in growing cells by E2F1, E2F2 and E2F3 (Weinmann et al. 2001, Bracken
    et al. 2003). H3K27Me3 mark serves as a docking site for the Polycomb repressor
    complex 1 (PRC1) that contains BMI1 (PCGF4) and is therefore named PRC1.4, leading
    to the repression of transcription of p16INK4A and p14ARF from the CDKN2A locus,
    where PCR1.4 mediated repression of p14ARF transcription in humans may be context
    dependent (Voncken et al. 2005, Dietrich et al. 2007, Agherbi et al. 2009, Gao
    et al. 2012). MAPKAPK2 and MAPKAPK3, activated downstream of the MAP3K5-p38 MAPK
    cascade, phosphorylate BMI1 of the PRC1.4 complex, leading to dissociation of
    PRC1.4 complex from the CDKN2A locus and upregulation of p14ARF transcription
    (Voncken et al. 2005). AP-1 transcription factor, formed as a result of MAP3K5-JNK
    signaling, as well as RAS signaling, binds the promoter of KDM6B (JMJD3) gene
    and stimulates KDM6B expression. KDM6B is a histone demethylase that removes H3K27Me3
    mark i.e. demethylates lysine K28 of HIST1H3A, thereby preventing PRC1.4 binding
    to the CDKN2A locus and allowing transcription of p16INK4A (Agger et al. 2009,
    Barradas et al. 2009, Lin et al. 2012).<p> <br>p16INK4A inhibits phosphorylation-mediated
    inactivation of RB family members by CDK4 and CDK6, leading to cell cycle arrest
    (Serrano et al. 1993). p14ARF inhibits MDM2-mediated degradation of TP53 (p53)
    (Zhang et al. 1998), which also contributes to cell cycle arrest in cells undergoing
    oxidative stress. In addition, phosphorylation of TP53 by MAPKAPK5 (PRAK) activated
    downstream of MAP3K5-p38 MAPK signaling, activates TP53 and contributes to cellular
    senescence (Sun et al. 2007).   View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=2559580
    Reactome].
  keywords:
  - 'UBB(153-228) '
  - 'E2F2 '
  - 'BMI1 '
  - Senescence-Associated Secretory Phenotype (SASP)
  - p38 MAPK:MAPKAPK2,3
  - 'EED '
  - 'TFDP1 '
  - Gene:E2F1/2/3:DP1/2
  - 'MINK1 '
  - 'HIST1H2AB '
  - 'EED Gene '
  - 'Me3K-28-H3F3A '
  - 'CBX8 '
  - KDM6B
  - Fe2+
  - DNA Damage/Telomere
  - ROS
  - 'p-T180,Y182-MAPK11 '
  - 'phospho-p38 MAPK:'
  - MAP3K5:TXN
  - 'MAPK11 '
  - 'MAP4K4 gene '
  - 'HIST1H2BA '
  - 'RING1 '
  - p-S189,T193-MAP2K3,
  - 'TP53 '
  - MAPKAPK2,3
  - 'TFDP2 '
  - miR-24
  - PolyUb-TP53 Tetramer
  - 'EZH2 '
  - 'Me3K-28-HIST1H3A '
  - p-T325,T331,S362,S374-FOS
  - 'p-S207,T211-MAP2K6 '
  - 'UBC(609-684) '
  - ADP
  - 'E2F3 '
  - IFNB1
  - 'RNF2 '
  - 'p-T182-MAPKAPK5 '
  - 'p14ARF mRNA '
  - 'HIST2H2AA3 '
  - 'SUZ12 Gene '
  - Checkpoints
  - 'KDM6B Gene '
  - EZH2 Gene
  - CDKN2A
  - RBBP4
  - p16INK4A/p14ARF
  - 'TXN '
  - 'p-S-BMI1 '
  - 'p-S271,T275-MAP2K7 '
  - 'HIST1H2BD '
  - 'UBC(305-380) '
  - 'p-S257,T261-MAP2K4 '
  - p-MAPK8,9,10
  - EED Gene
  - 'p14ARF '
  - p-2S-cJUN:p-2S,2T-cFOS:KDM6B Gene
  - Oncogenic MAPK
  - EED
  - 'UBB(1-76) '
  - p38 MAPK:MAPKAPK5
  - 'CDK6 '
  - p14ARF mRNA
  - 'HIST1H2BK '
  - 'UBC(77-152) '
  - 'TNIK '
  - 'TNIK gene '
  - 'mRNA: miR-24'
  - 'PHC3 '
  - 'UBC(229-304) '
  - p-S166,S188-MDM2,MDM4:TP53
  - 'SUZ12 '
  - 'SCMH1-2 '
  - 'UBC(1-76) '
  - p38:p-MAPKAPK3
  - 'CDKN2D '
  - Mitotic G1 phase and
  - 'p-T183,Y185-MAPK9 '
  - signaling
  - 'MAPKAPK5 '
  - 'UBC(381-456) '
  - 'PHC2 '
  - 'UBC(153-228) '
  - 'CBX4 '
  - JUN
  - 'RBBP4 '
  - MINK1/TNIK genes
  - 'H2AFZ '
  - AdoHcy
  - 'KDM6B '
  - 'Fe2+ '
  - 'MINK1 gene '
  - p16INK4A mRNA
  - 'p16INK4A mRNA '
  - 'EIF2C1 '
  - 'HIST1H2BH '
  - E2F1,E2F2,E2F3:TFDP1,TFDP2
  - p16INK4A/p14ARF mRNA
  - 'p16INK4A '
  - 'HIST1H4 '
  - p-2S-cJUN:p-2S,2T-cFOS
  - 'CDKN2C '
  - 2OG
  - 'CDKN2A gene '
  - 'MAPKAPK3 '
  - 'MAPK10 '
  - 'UBA52(1-76) '
  - 'HIST2H3A '
  - 'MOV10 '
  - 'CBX2 '
  - Nonendonucleolytic
  - 'HIST1H2AC '
  - 'p-S63,S73-JUN '
  - 'MAP4K4 '
  - MINK1/TNIK
  - 'p-T,Y-MAPK8 '
  - 'miR-24-2 '
  - 'MAP2K6 '
  - p14ARF:p-S166,S188-MDM2 dimer,p-S166,S188-MDM2:MDM4
  - ATP
  - Ub
  - 'MDM4 '
  - 'PHC1 '
  - 'PolyUb-TP53 '
  - 'UBC(457-532) '
  - p-PRC1.4 complex
  - 'E2F1 '
  - SUZ12 Gene
  - 'MAP3K5 '
  - 'UBC(533-608) '
  - Oncogene Induced
  - 'HIST2H2BE '
  - 'UBB(77-152) '
  - 'H2AFJ '
  - for Apoptosis
  - 'p-S189,T193-MAP2K3 '
  - CDKN2A gene
  - Gene:H3K27Me3-Nucleosome
  - p-p38
  - p-S166,S188-MDM2:MDM4
  - phospho-MAPK
  - 'MAP2K3 '
  - 'MAPK14 '
  - KDM6B Gene
  - 'HIST1H2BM '
  - 'p-S37-TP53 '
  - 'H2BFS '
  - 'p-T202,Y204-MAPK3 '
  - RISC
  - 'MAPKAPK2 '
  - 'HIST1H2AD '
  - 'HIST1H2BN '
  - MAP3K5
  - 2xHC-TXN
  - SUZ12
  - EZH2
  - 'p-S166,S188-MDM2 '
  - 'H2AFB1 '
  - 'H2AFX '
  - 'EIF2C3 '
  - p-S63,S73-JUN
  - Cell Cycle
  - dimer,
  - 'HIST1H2BJ '
  - 'HIST1H2AJ '
  - 'EIF2C4 '
  - 'MAPK8 '
  - G1/S transition
  - phospho-p38
  - FOS
  - 'HIST3H2BB '
  - 'p-T222,S272,T334-MAPKAPK2 '
  - 'p-T180,Y182-MAPK14 '
  - MAP2K4
  - TP53 Tetramer
  - RBBP7
  - p-S166,S188-MDM2
  - 'HIST1H2BL '
  - 'TNRC6C '
  - 'miR-24-1 '
  - p-S257,T261-MAP2K4
  - 'EZH2 Gene '
  - p-S37-TP53 Tetramer
  - 'TNRC6B '
  - 'H3F3A '
  - Intrinsic Pathway
  - MAPK:p-MAPKAPK2/3
  - 'CDK4 '
  - MAPKAPK5
  - 'RBBP7 '
  - SUCCA
  - PRC2 (EZH2) Core
  - Gene:H3K27Me3-Nucleosome:PRC1.4
  - 'HIST1H2BB '
  - PRC1.4
  - 'H2AFV '
  - 'CDKN2B '
  - p14ARF:p-S166,S188-MDM2 dimer,p-S166,S188-MDM2:MDM4:TP53
  - CDK4,CDK6
  - 'HIST1H3A '
  - 'HIST1H2BC '
  - CDK4,CDK6:INK4
  - 'p-T325,T331,S362,S374-FOS '
  - 'p-T221,Y223-MAPK10 '
  - p-T,Y MAPK dimers
  - Stress Induced
  - KDM6B:Fe2+
  - Senescence
  - 'p-p38 MAPK:'
  - AdoMet
  - MAP2K3,MAP2K6
  - 'p-T185,Y187-MAPK1 '
  - p14ARF
  - MAPK8,9,10
  - 'HIST2H2AC '
  - 'p-S,2T-MAPKAPK3 '
  - 'Me3K-28-HIST2H3A '
  - 'TNRC6A '
  - p16INK4A
  - 'HIST1H2BO '
  - MAPK:p-T-182-MAPKAPK5
  - p-MAP2K4/p-MAP2K7
  - INK4
  - p-S207,T211-MAP2K6
  - 'MAPK9 '
  - Gene:Nucleosome
  - 'CBX6 '
  - 'RPS27A(1-76) '
  license: CC0
  name: Oxidative Stress Induced Senescence
seo: CreativeWork
title: Oxidative Stress Induced Senescence
wpid: WP3404
---